Monthly Archives: October 2022

Photosoft compounds demonstrated ≥99% inhibition against Zika virus in cell-based assays following the application of light. Zika virus is found in 86 countries and has been linked to birth defects and other neurological complications. The Zika virus market is to be worth ~US$17 billion in 2022 with no treatments for the disease currently available. Several…

Combination therapy of INV043 and immune checkpoint inhibitors ("ICI") shown to be more effective compared to standalone ICI therapy, resulting in ~65% reduction of tumour size in mice. Despite widespread clinical use as a monotherapy, ICI's effectiveness is typically limited to a smaller proportion of the cancer patient population. (more…)